English
  • head_banner_01
ʻO Hexarelin Kiʻi Hōʻikeʻike
  • Hexarelin

Hexarelin

ʻO ka wehewehe pōkole:

ʻO Hexarelin kahi synthetic growth hormone secretagogue peptide (GHS) a me ka potent GHSR-1a agonist, i hoʻomohala ʻia e hoʻoulu i ka hoʻokuʻu ʻana o ka hormone ulu (GH). No ka ʻohana mimetic ghrelin a ua haku ʻia me ʻeono amino acids (hexapeptide), e hāʻawi ana i ka hoʻomaikaʻi ʻana i ka metabolic stability a me nā hopena hoʻokuʻu GH ikaika i hoʻohālikelike ʻia me nā analogs mua e like me GHRP-6.

Nā hiʻohiʻona API:

Maʻemaʻe ≥ 99%

Hana ʻia ma o ka solid-phase peptide synthesis (SPPS)

Nā kūlana like GMP, endotoxin haʻahaʻa a me nā koena solvent

Hāʻawi maʻalahi: R&D i ka pālākiō kalepa


Huahana Huahana

Huahana Huahana

Hexarelin API - Nānā Huahana

Hexarelinhe mea syntheticʻO ka ulu ʻana o ka hormone secretagogue peptide (GHS)a ikaikaGHSR-1a agonist, hoʻomohala e hoʻouluhoʻokuʻu ʻia ka hormone ulu ulu (GH).. No kaʻohana mimetic ghrelina ua haku ʻia he ʻeono amino acids (hexapeptide), e hāʻawi ana i ka hoʻomaikaʻi ʻana i ka metabolic stability a me nā hopena hoʻokuʻu GH ikaika i hoʻohālikelike ʻia me nā analogs mua e like me GHRP-6.

Ua aʻo nui ʻia ʻo Hexarelin no kāna mau noi maʻo ka endocrinology, ka hoʻopau ʻana i ka ʻiʻo, ka hoʻoponopono ʻana i ka naʻau, a me nā lāʻau anti-kahiko, ma muli o kona hiki ke hoʻokiʻekiʻe maoli i ka GH amea ulu e like me ka insulin 1 (IGF-1)nā pae me ka hoʻokomo ʻole ʻana i nā hormones waho.

Mechanism of Action

Hoʻopili ʻo Hexarelin i kaʻO ka mea hoʻokipa homoni ulu ulu (GHSR-1a)ma ka pituitary a me ka hypothalamus, e hoohalike ana i ka hana oghrelin—ka pōloli maoli o ke kino a me ka hormone hoʻokuʻu GH.

Nā hana physiological nui:

  • Hoʻoulu i ka hoʻokuʻu GH pulsatile

  • Hoʻonui kaʻapuniIGF-1pae

  • Hoʻolahahopena anabolic(ka ulu ʻana o ka ʻiʻo, hoʻihoʻi hou)

  • Kākoʻomomona metabolismahoʻoulu hou ʻana o ke kelepona

  • Hiki ke hōʻikecardioprotectiveaanti-apoptotichopena

ʻAʻole like me kekahi mau peptides GHS, hana ʻo HexarelinʻAʻole hoʻonui nui i ka cortisol a i ʻole prolactin, e hāʻawi ana i kahi ʻike endocrine maʻemaʻe.

Noiʻi a me ka lāʻau lapaʻau

1. Ka Ulu a me ka Ho'ōla

  • Hoʻolahanui kino wiwihooulu ana

  • Hoʻonuihoʻoponopono a hoʻoponopono hou

  • Ua aʻo ʻia masarcopenia, cachexia, a me ka hoʻihoʻi ʻana ma hope o ka ʻoki ʻana

2. Palekana maʻi maʻi

  • Hōʻike nā haʻawina preclinicalhoʻomaikaʻi i ka hana naʻauma hope o ka ʻeha myocardial

  • Hoemifibrosis puʻuwaia hoʻonuihaʻihaʻi hoʻokuʻu ventricular hema

  • Hiki ke hoʻohana mapuʻuwai hāʻuleaʻelemakule naʻaunā hiʻohiʻona

3. ʻO ka Metabolism momona a me ka Anti-Aging

  • Hoʻonuilipolysisa hoʻomaikaʻiʻike i ka insulin

  • Kākoʻonā lāʻau lapaʻau kūʻē i ka wā kahikoma o GH/IGF-1 axis stimulation

  • Hiki ke kōkua i ka mālama ʻanaiwi iwi a me ke ola hui

Nā hiʻohiʻona API (Gentolex Group)

  • Maʻemaʻe ≥ 99%

  • Hana ʻia ma oka hana peptide synthesis (SPPS)

  • Nā kūlana like GMP, endotoxin haʻahaʻa a me nā koena solvent

  • lako hikiwawe:R&D i ka pālākiō pāʻoihana

  • Mua:
  • Aʻe:
    • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou

    PiliHANA

    E kaomi i ke komo no ka huli ʻana a i ʻole ESC e pani